Company Overview and News

Ausgold to raise funds post acquisition

Ausgold Ltd (ASX:AUC) recently completed the acquisition of the Dumbleyung Gold Project in Katanning, Western Australia.

Ausgold gets ready to raise

Ausgold (ASX:AUC) has been granted a trading halt by the ASX this morning, pending details of a capital raising.

Ausgold to assess gold potential at Doolgunna project

Ausgold Ltd (ASX:AUC) is commencing a reconnaissance field mapping and geochemical sampling program at its Doolgunna Station Project in Western Australia’s Bryah Basin. The Doolgunna Mineral Field is one of the most significant copper-gold provinces in Australia, producing in excess of 8 million ounces of gold to date. The project is located adjacent to Sandfire Resources NL’s (ASX:SFR) DeGrussa copper-gold project, immediately north of the Hermes gold deposit and south-east of the Plutonic gold mine.

Ausgold Ltd teams up with engineering partner for Katanning Gold

Ausgold Ltd (ASX:AUC) has appointed GR Engineering Services Ltd (ASX:GNG) as its preferred provider of engineering services for the Katanning Gold Project in Western Australia. GRES will provide services associated with the feasibility study, engineering design, construction and commissioning of processing facilities at Katanning, located 275 kilometres southeast of Perth. Geoffrey Jones, managing director of GR Engineering, has been appointed to Ausgold’s board as a non-executive director.

Ausgold Ltd to lift cash position ahead of gold drilling

Ausgold Ltd (ASX:AUC) is heading to market with a capital raising, and the ASX has granted the company a trading halt to prepare. Ausgold currently has a focus on drilling at the Katanning Gold Project, located in Western Australia. The halt will remain in place until the opening of trade on Tuesday 19th July 2016, or earlier if an announcement is made to the market.

Results of General Meeting


Ausgold Ltd finds high-grade gold shoots at Katanning project

Ausgold Ltd (ASX:AUC) has received encouraging high grade assay results from reverse circulation drilling at the Katanning Gold Project located 275 kilometres southeast of Perth. The presence of wide gold mineralised halos contain high grade, pipe-like shoots at the White Dam and Jackson prospects. The high-grade assay results from White Dam included 9 metres at 8.15 g/t gold from 145 metres including 5 metres at 14.

Cancellation of Unlisted Options


Board Changes


Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...